These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25755199)

  • 1. In reference to "Use of paracentesis in hospitalized patients with decompensated cirrhosis and ascites: Opportunities for quality improvement".
    Soni NJ; Franco-Sadud R
    J Hosp Med; 2015 May; 10(5):342. PubMed ID: 25755199
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of paracentesis in hospitalized patients with decompensated cirrhosis and ascites: opportunities for quality improvement.
    Brooling J; Ghaoui R; Lindenauer PK; Friderici J; Lagu T
    J Hosp Med; 2014 Dec; 9(12):797-9. PubMed ID: 25347954
    [No Abstract]   [Full Text] [Related]  

  • 3. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
    Gaetano JN; Micic D; Aronsohn A; Reddy G; Te H; Reau NS; Jensen D
    J Gastroenterol Hepatol; 2016 May; 31(5):1025-30. PubMed ID: 26642977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIPS versus paracentesis for the treatment of refractory ascites.
    Lau A; Bay C; Nadir A
    Hepatology; 2004 Dec; 40(6):1476; author reply 1476-7. PubMed ID: 15565609
    [No Abstract]   [Full Text] [Related]  

  • 5. TIPS in refractory ascites in cirrhosis: not only survival is the clue.
    Ockenga J; Schuetz T; Lochs H
    Gastroenterology; 2003 Sep; 125(3):997-8. PubMed ID: 12974267
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
    Licata G; Tuttolomondo A; Licata A; Parrinello G; Di Raimondo D; Di Sciacca R; Cammà C; Craxì A; Paterna S; Pinto A
    Aliment Pharmacol Ther; 2009 Aug; 30(3):227-35. PubMed ID: 19438847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
    Aalykke C; Tønner-Nielsen D; Vilstrup H
    Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: long-term abdominal drains in refractory ascites-evolving concept of palliative care in decompensated cirrhosis.
    Roy A; Taneja S; Duseja AK; Singh V
    Aliment Pharmacol Ther; 2020 Oct; 52(7):1266-1267. PubMed ID: 33016534
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites.
    Knudsen AW; Krag A; Nordgaard-Lassen I; Frandsen E; Tofteng F; Mortensen C; Becker U
    Scand J Gastroenterol; 2016; 51(5):601-9. PubMed ID: 26673350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: long-term abdominal drains in refractory ascites-evolving concept of palliative care in decompensated cirrhosis. Authors' reply.
    Macken L; Bremner S; Sheridan D; Verma S
    Aliment Pharmacol Ther; 2020 Oct; 52(7):1268-1269. PubMed ID: 33016545
    [No Abstract]   [Full Text] [Related]  

  • 12. Could Adherence to Quality of Care Indicators for Hospitalized Patients With Cirrhosis-Related Ascites Improve Clinical Outcomes?
    Le S; Spelman T; Chong CP; Ha P; Sahhar L; Lim J; He T; Heerasing N; Sievert W
    Am J Gastroenterol; 2016 Jan; 111(1):87-92. PubMed ID: 26729545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study.
    Bucsics T; Mandorfer M; Schwabl P; Bota S; Sieghart W; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1657-65. PubMed ID: 25967931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump.
    Kumar K; Pillai VB
    Liver Transpl; 2020 Nov; 26(11):1539-1540. PubMed ID: 32578929
    [No Abstract]   [Full Text] [Related]  

  • 16. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.
    Zhao J; Yuan C; Wang D; Li X
    Chin Med J (Engl); 2000 Jan; 113(1):27-30. PubMed ID: 11775204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of refractory ascites in patients with cirrhosis.
    Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
    J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renaissance of paracentesis in the treatment of ascites.
    Reynolds TB
    Adv Intern Med; 1990; 35():365-73. PubMed ID: 2405598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing Hospital Admissions for Paracentesis: A Quality Improvement Intervention.
    Siddique SM; Porges S; Lane-Fall M; Mehta SJ; Schweickert W; Kinniry J; Taylor A; Lewis JD; Iqbal S; Goldberg D; Shea JA; Stetson R; Coniglio M; Hoteit M; Fishman N; Khungar V
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2630-2633.e2. PubMed ID: 31518719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.